Ebi H - Search Results

1

Path-Planning System for Radioisotope Identification Devices Using 4π Gamma Imaging Based on Random Forest Analysis.

Tomita H, Hara S, Mukai A, Yamagishi K, Ebi H, Shimazoe K, Tamura Y, Woo H, Takahashi H, Asama H, Ishida F, Takada E, Kawarabayashi J, Tanabe K, Kamada K. Tomita H, et al. Among authors: ebi h. Sensors (Basel). 2022 Jun 7;22(12):4325. doi: 10.3390/s22124325. Sensors (Basel). 2022. PMID: 35746105 Free PMC article.

2

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.

Yoshino T, Cervantes A, Bando H, Martinelli E, Oki E, Xu RH, Mulansari NA, Govind Babu K, Lee MA, Tan CK, Cornelio G, Chong DQ, Chen LT, Tanasanvimon S, Prasongsook N, Yeh KH, Chua C, Sacdalan MD, Sow Jenson WJ, Kim ST, Chacko RT, Syaiful RA, Zhang SZ, Curigliano G, Mishima S, Nakamura Y, Ebi H, Sunakawa Y, Takahashi M, Baba E, Peters S, Ishioka C, Pentheroudakis G. Yoshino T, et al. Among authors: ebi h. ESMO Open. 2023 Jun;8(3):101558. doi: 10.1016/j.esmoop.2023.101558. Epub 2023 May 24. ESMO Open. 2023. PMID: 37236086 Free PMC article.

3

Oncogene alterations in non-small cell lung cancer with FGFR1 amplification-novel approach to stratify patients who benefit from FGFR inhibitors.

Kitai H, Ebi H. Kitai H, et al. Among authors: ebi h. Transl Lung Cancer Res. 2024 Mar 29;13(3):684-688. doi: 10.21037/tlcr-23-777. Epub 2024 Mar 8. Transl Lung Cancer Res. 2024. PMID: 38601453 Free PMC article. No abstract available.

4

Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM.

Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Nishio M, Kato T, Takahashi T, Ebi H, Aono M, Yamamoto N, Ohe Y, Nakagawa K. Watanabe S, et al. Among authors: ebi h. ESMO Open. 2024 Mar 22;9(4):102975. doi: 10.1016/j.esmoop.2024.102975. Online ahead of print. ESMO Open. 2024. PMID: 38520847 Free PMC article.

5

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

Bando H, Yamaguchi K, Mitani S, Sawada K, Mishima S, Komine K, Okugawa Y, Hosoda W, Ebi H. Bando H, et al. Among authors: ebi h. Cancer Sci. 2024 Mar;115(3):1014-1021. doi: 10.1111/cas.16039. Epub 2024 Jan 23. Cancer Sci. 2024. PMID: 38263580 Free PMC article.

6

SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.

Lai X, Lui SKL, Lam HY, Adachi Y, Sim WJ, Vasilevski N, Armstrong NJ, Bridgeman SC, Main NM, Tan TZ, Tirnitz-Parker JEE, Thiery JP, Ebi H, Kumar AP, Eichhorn PJA. Lai X, et al. Among authors: ebi h. NPJ Precis Oncol. 2023 Dec 15;7(1):136. doi: 10.1038/s41698-023-00486-6. NPJ Precis Oncol. 2023. PMID: 38102334 Free PMC article.

7

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.

Matsubara J, Mukai K, Kondo T, Yoshioka M, Kage H, Oda K, Kudo R, Ikeda S, Ebi H, Muro K, Hayashi R, Tokudome N, Yamamoto N, Muto M. Matsubara J, et al. Among authors: ebi h. JAMA Netw Open. 2023 Jul 3;6(7):e2323336. doi: 10.1001/jamanetworkopen.2023.23336. JAMA Netw Open. 2023. PMID: 37459099 Free PMC article.

8

Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS.

Adachi Y, Kimura R, Hirade K, Yanase S, Nishioka Y, Kasuga N, Yamaguchi R, Ebi H. Adachi Y, et al. Among authors: ebi h. Nat Cancer. 2023 Jun;4(6):829-843. doi: 10.1038/s43018-023-00575-2. Epub 2023 Jun 5. Nat Cancer. 2023. PMID: 37277529

9

Diagnostic utility of DNA integrity number as an indicator of sufficient DNA quality in next-generation sequencing-based genomic profiling.

Hiramatsu K, Matsuda C, Masago K, Toriyama K, Sasaki E, Fujita Y, Haneda M, Ebi H, Shibata N, Hosoda W. Hiramatsu K, et al. Among authors: ebi h. Am J Clin Pathol. 2023 Sep 1;160(3):261-267. doi: 10.1093/ajcp/aqad046. Am J Clin Pathol. 2023. PMID: 37167067

10

Drug-Tolerant Persister Cells After EGFR Tyrosine Kinase Inhibitor Treatment: Their Origin and the Influences From the Tumor Microenvironment.

Ebi H. Ebi H. J Thorac Oncol. 2023 Apr;18(4):399-401. doi: 10.1016/j.jtho.2022.12.010. J Thorac Oncol. 2023. PMID: 36990572 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page